nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—CYP2D6—Fingolimod—multiple sclerosis	0.0497	0.261	CbGbCtD
Ropinirole—HTR1B—trigeminal nucleus—multiple sclerosis	0.0392	0.172	CbGeAlD
Ropinirole—HTR1D—trigeminal nucleus—multiple sclerosis	0.0379	0.167	CbGeAlD
Ropinirole—CYP3A4—Fingolimod—multiple sclerosis	0.0316	0.166	CbGbCtD
Ropinirole—HTR1D—meninx—multiple sclerosis	0.0252	0.111	CbGeAlD
Ropinirole—CYP3A4—Methylprednisolone—multiple sclerosis	0.0203	0.107	CbGbCtD
Ropinirole—HTR2A—trigeminal nucleus—multiple sclerosis	0.0188	0.0828	CbGeAlD
Ropinirole—CYP3A4—Triamcinolone—multiple sclerosis	0.0154	0.0811	CbGbCtD
Ropinirole—CYP3A4—Mitoxantrone—multiple sclerosis	0.0148	0.078	CbGbCtD
Ropinirole—CYP3A4—Betamethasone—multiple sclerosis	0.0132	0.0696	CbGbCtD
Ropinirole—CYP3A4—Prednisolone—multiple sclerosis	0.0131	0.0686	CbGbCtD
Ropinirole—CYP3A4—Prednisone—multiple sclerosis	0.0123	0.0648	CbGbCtD
Ropinirole—CYP2D6—Dexamethasone—multiple sclerosis	0.0121	0.0636	CbGbCtD
Ropinirole—HTR1B—trigeminal nerve—multiple sclerosis	0.0103	0.0452	CbGeAlD
Ropinirole—HTR1D—trigeminal nerve—multiple sclerosis	0.00996	0.0438	CbGeAlD
Ropinirole—CYP3A4—Dexamethasone—multiple sclerosis	0.0077	0.0405	CbGbCtD
Ropinirole—HTR2A—trigeminal nerve—multiple sclerosis	0.00495	0.0218	CbGeAlD
Ropinirole—DRD1—nerve—multiple sclerosis	0.00464	0.0204	CbGeAlD
Ropinirole—HTR2A—pons—multiple sclerosis	0.00348	0.0153	CbGeAlD
Ropinirole—DRD2—nerve—multiple sclerosis	0.00274	0.012	CbGeAlD
Ropinirole—ADRA2A—peripheral nervous system—multiple sclerosis	0.00272	0.012	CbGeAlD
Ropinirole—HTR2A—pineal body—multiple sclerosis	0.00249	0.0109	CbGeAlD
Ropinirole—HTR2A—peripheral nervous system—multiple sclerosis	0.00232	0.0102	CbGeAlD
Ropinirole—DRD1—brainstem—multiple sclerosis	0.00199	0.00875	CbGeAlD
Ropinirole—HTR2A—nerve—multiple sclerosis	0.00181	0.00794	CbGeAlD
Ropinirole—HTR1B—brainstem—multiple sclerosis	0.00161	0.00709	CbGeAlD
Ropinirole—DRD4—brain—multiple sclerosis	0.00158	0.00696	CbGeAlD
Ropinirole—HTR1D—brainstem—multiple sclerosis	0.00156	0.00686	CbGeAlD
Ropinirole—HTR2C—brainstem—multiple sclerosis	0.00155	0.0068	CbGeAlD
Ropinirole—DRD3—nervous system—multiple sclerosis	0.00146	0.0064	CbGeAlD
Ropinirole—DRD3—central nervous system—multiple sclerosis	0.0014	0.00616	CbGeAlD
Ropinirole—DRD5—nervous system—multiple sclerosis	0.00136	0.006	CbGeAlD
Ropinirole—DRD5—central nervous system—multiple sclerosis	0.00131	0.00578	CbGeAlD
Ropinirole—HTR1A—brainstem—multiple sclerosis	0.0013	0.00572	CbGeAlD
Ropinirole—DRD1—midbrain—multiple sclerosis	0.00127	0.00558	CbGeAlD
Ropinirole—DRD2—brainstem—multiple sclerosis	0.00118	0.00517	CbGeAlD
Ropinirole—DRD2—retina—multiple sclerosis	0.00113	0.00499	CbGeAlD
Ropinirole—DRD3—brain—multiple sclerosis	0.00111	0.00489	CbGeAlD
Ropinirole—HTR2C—medulla oblongata—multiple sclerosis	0.00108	0.00474	CbGeAlD
Ropinirole—DRD5—brain—multiple sclerosis	0.00104	0.00459	CbGeAlD
Ropinirole—DRD1—nervous system—multiple sclerosis	0.00104	0.00458	CbGeAlD
Ropinirole—HTR1B—midbrain—multiple sclerosis	0.00103	0.00452	CbGeAlD
Ropinirole—DRD1—central nervous system—multiple sclerosis	0.001	0.00441	CbGeAlD
Ropinirole—HTR1B—spinal cord—multiple sclerosis	0.001	0.00441	CbGeAlD
Ropinirole—HTR1D—midbrain—multiple sclerosis	0.000995	0.00437	CbGeAlD
Ropinirole—HTR2C—midbrain—multiple sclerosis	0.000985	0.00433	CbGeAlD
Ropinirole—HTR2C—spinal cord—multiple sclerosis	0.000961	0.00423	CbGeAlD
Ropinirole—HTR1B—nervous system—multiple sclerosis	0.000845	0.00371	CbGeAlD
Ropinirole—HTR1A—midbrain—multiple sclerosis	0.000829	0.00365	CbGeAlD
Ropinirole—HTR1D—nervous system—multiple sclerosis	0.000818	0.0036	CbGeAlD
Ropinirole—HTR1B—central nervous system—multiple sclerosis	0.000813	0.00358	CbGeAlD
Ropinirole—HTR2C—nervous system—multiple sclerosis	0.00081	0.00356	CbGeAlD
Ropinirole—HTR1A—spinal cord—multiple sclerosis	0.000809	0.00356	CbGeAlD
Ropinirole—ADRA2C—medulla oblongata—multiple sclerosis	0.000797	0.0035	CbGeAlD
Ropinirole—DRD1—brain—multiple sclerosis	0.000797	0.0035	CbGeAlD
Ropinirole—HTR1D—central nervous system—multiple sclerosis	0.000787	0.00346	CbGeAlD
Ropinirole—HTR2C—central nervous system—multiple sclerosis	0.00078	0.00343	CbGeAlD
Ropinirole—HTR2A—brainstem—multiple sclerosis	0.000775	0.00341	CbGeAlD
Ropinirole—HTR2B—nervous system—multiple sclerosis	0.000761	0.00335	CbGeAlD
Ropinirole—DRD2—midbrain—multiple sclerosis	0.000749	0.00329	CbGeAlD
Ropinirole—HTR2A—retina—multiple sclerosis	0.000748	0.00329	CbGeAlD
Ropinirole—HTR2B—central nervous system—multiple sclerosis	0.000732	0.00322	CbGeAlD
Ropinirole—ADRA2C—midbrain—multiple sclerosis	0.000728	0.0032	CbGeAlD
Ropinirole—ADRA2C—spinal cord—multiple sclerosis	0.000711	0.00313	CbGeAlD
Ropinirole—CYP2D6—brainstem—multiple sclerosis	0.000706	0.00311	CbGeAlD
Ropinirole—HTR1A—nervous system—multiple sclerosis	0.000682	0.003	CbGeAlD
Ropinirole—HTR1A—central nervous system—multiple sclerosis	0.000656	0.00289	CbGeAlD
Ropinirole—HTR1B—brain—multiple sclerosis	0.000646	0.00284	CbGeAlD
Ropinirole—HTR1A—cerebellum—multiple sclerosis	0.000641	0.00282	CbGeAlD
Ropinirole—ADRA2A—medulla oblongata—multiple sclerosis	0.000636	0.0028	CbGeAlD
Ropinirole—HTR1D—brain—multiple sclerosis	0.000625	0.00275	CbGeAlD
Ropinirole—HTR2C—brain—multiple sclerosis	0.000619	0.00272	CbGeAlD
Ropinirole—DRD2—nervous system—multiple sclerosis	0.000616	0.00271	CbGeAlD
Ropinirole—ADRA2C—nervous system—multiple sclerosis	0.000599	0.00263	CbGeAlD
Ropinirole—DRD2—central nervous system—multiple sclerosis	0.000593	0.00261	CbGeAlD
Ropinirole—HTR2B—brain—multiple sclerosis	0.000581	0.00256	CbGeAlD
Ropinirole—ADRA2A—midbrain—multiple sclerosis	0.000581	0.00256	CbGeAlD
Ropinirole—DRD2—cerebellum—multiple sclerosis	0.00058	0.00255	CbGeAlD
Ropinirole—ADRA2C—central nervous system—multiple sclerosis	0.000576	0.00254	CbGeAlD
Ropinirole—ADRA2A—spinal cord—multiple sclerosis	0.000567	0.00249	CbGeAlD
Ropinirole—ADRA2C—cerebellum—multiple sclerosis	0.000563	0.00248	CbGeAlD
Ropinirole—HTR2A—medulla oblongata—multiple sclerosis	0.000541	0.00238	CbGeAlD
Ropinirole—HTR1A—brain—multiple sclerosis	0.000521	0.00229	CbGeAlD
Ropinirole—HTR2A—midbrain—multiple sclerosis	0.000494	0.00217	CbGeAlD
Ropinirole—HTR2A—spinal cord—multiple sclerosis	0.000482	0.00212	CbGeAlD
Ropinirole—ADRA2A—nervous system—multiple sclerosis	0.000478	0.0021	CbGeAlD
Ropinirole—DRD2—brain—multiple sclerosis	0.000471	0.00207	CbGeAlD
Ropinirole—ADRA2A—central nervous system—multiple sclerosis	0.00046	0.00202	CbGeAlD
Ropinirole—ADRA2C—brain—multiple sclerosis	0.000458	0.00201	CbGeAlD
Ropinirole—ADRA2A—cerebellum—multiple sclerosis	0.00045	0.00198	CbGeAlD
Ropinirole—HTR2A—nervous system—multiple sclerosis	0.000406	0.00179	CbGeAlD
Ropinirole—HTR2A—central nervous system—multiple sclerosis	0.000391	0.00172	CbGeAlD
Ropinirole—HTR2A—cerebellum—multiple sclerosis	0.000382	0.00168	CbGeAlD
Ropinirole—CYP3A4—nervous system—multiple sclerosis	0.000376	0.00165	CbGeAlD
Ropinirole—CYP2D6—nervous system—multiple sclerosis	0.00037	0.00163	CbGeAlD
Ropinirole—ADRA2A—brain—multiple sclerosis	0.000365	0.00161	CbGeAlD
Ropinirole—CYP3A4—central nervous system—multiple sclerosis	0.000362	0.00159	CbGeAlD
Ropinirole—CYP2D6—central nervous system—multiple sclerosis	0.000356	0.00157	CbGeAlD
Ropinirole—CYP2D6—cerebellum—multiple sclerosis	0.000348	0.00153	CbGeAlD
Ropinirole—HTR2A—brain—multiple sclerosis	0.000311	0.00137	CbGeAlD
Ropinirole—CYP2D6—brain—multiple sclerosis	0.000283	0.00124	CbGeAlD
Ropinirole—Loss of consciousness—Betamethasone—multiple sclerosis	0.000135	0.00032	CcSEcCtD
Ropinirole—Epistaxis—Methotrexate—multiple sclerosis	0.000135	0.00032	CcSEcCtD
Ropinirole—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000135	0.00032	CcSEcCtD
Ropinirole—Paraesthesia—Prednisolone—multiple sclerosis	0.000135	0.00032	CcSEcCtD
Ropinirole—Tachycardia—Triamcinolone—multiple sclerosis	0.000135	0.00032	CcSEcCtD
Ropinirole—Mental disorder—Prednisone—multiple sclerosis	0.000135	0.000319	CcSEcCtD
Ropinirole—Nausea—Azathioprine—multiple sclerosis	0.000135	0.000319	CcSEcCtD
Ropinirole—Tachycardia—Methylprednisolone—multiple sclerosis	0.000135	0.000319	CcSEcCtD
Ropinirole—Skin disorder—Methylprednisolone—multiple sclerosis	0.000134	0.000318	CcSEcCtD
Ropinirole—Malnutrition—Prednisone—multiple sclerosis	0.000134	0.000317	CcSEcCtD
Ropinirole—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000134	0.000317	CcSEcCtD
Ropinirole—Agranulocytosis—Methotrexate—multiple sclerosis	0.000134	0.000317	CcSEcCtD
Ropinirole—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000134	0.000316	CcSEcCtD
Ropinirole—Convulsion—Dexamethasone—multiple sclerosis	0.000134	0.000316	CcSEcCtD
Ropinirole—Convulsion—Betamethasone—multiple sclerosis	0.000134	0.000316	CcSEcCtD
Ropinirole—Hypertension—Dexamethasone—multiple sclerosis	0.000133	0.000315	CcSEcCtD
Ropinirole—Hypertension—Betamethasone—multiple sclerosis	0.000133	0.000315	CcSEcCtD
Ropinirole—Asthenia—Mitoxantrone—multiple sclerosis	0.000132	0.000312	CcSEcCtD
Ropinirole—Myalgia—Dexamethasone—multiple sclerosis	0.000131	0.00031	CcSEcCtD
Ropinirole—Myalgia—Betamethasone—multiple sclerosis	0.000131	0.00031	CcSEcCtD
Ropinirole—Anxiety—Dexamethasone—multiple sclerosis	0.000131	0.000309	CcSEcCtD
Ropinirole—Anxiety—Betamethasone—multiple sclerosis	0.000131	0.000309	CcSEcCtD
Ropinirole—Discomfort—Betamethasone—multiple sclerosis	0.00013	0.000307	CcSEcCtD
Ropinirole—Discomfort—Dexamethasone—multiple sclerosis	0.00013	0.000307	CcSEcCtD
Ropinirole—Haemoglobin—Methotrexate—multiple sclerosis	0.00013	0.000306	CcSEcCtD
Ropinirole—Hypotension—Methylprednisolone—multiple sclerosis	0.000129	0.000306	CcSEcCtD
Ropinirole—Pain—Prednisolone—multiple sclerosis	0.000129	0.000305	CcSEcCtD
Ropinirole—Haemorrhage—Methotrexate—multiple sclerosis	0.000129	0.000305	CcSEcCtD
Ropinirole—Pharyngitis—Methotrexate—multiple sclerosis	0.000128	0.000302	CcSEcCtD
Ropinirole—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000127	0.000301	CcSEcCtD
Ropinirole—Vision blurred—Prednisone—multiple sclerosis	0.000126	0.000299	CcSEcCtD
Ropinirole—Urethral disorder—Methotrexate—multiple sclerosis	0.000126	0.000299	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000126	0.000299	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000126	0.000298	CcSEcCtD
Ropinirole—Oedema—Dexamethasone—multiple sclerosis	0.000126	0.000298	CcSEcCtD
Ropinirole—Oedema—Betamethasone—multiple sclerosis	0.000126	0.000298	CcSEcCtD
Ropinirole—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000126	0.000297	CcSEcCtD
Ropinirole—Insomnia—Triamcinolone—multiple sclerosis	0.000125	0.000297	CcSEcCtD
Ropinirole—Insomnia—Methylprednisolone—multiple sclerosis	0.000125	0.000296	CcSEcCtD
Ropinirole—Infection—Dexamethasone—multiple sclerosis	0.000125	0.000296	CcSEcCtD
Ropinirole—Infection—Betamethasone—multiple sclerosis	0.000125	0.000296	CcSEcCtD
Ropinirole—Ill-defined disorder—Prednisone—multiple sclerosis	0.000125	0.000295	CcSEcCtD
Ropinirole—Paraesthesia—Triamcinolone—multiple sclerosis	0.000124	0.000294	CcSEcCtD
Ropinirole—Feeling abnormal—Prednisolone—multiple sclerosis	0.000124	0.000294	CcSEcCtD
Ropinirole—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000124	0.000294	CcSEcCtD
Ropinirole—Visual impairment—Methotrexate—multiple sclerosis	0.000124	0.000294	CcSEcCtD
Ropinirole—Anaemia—Prednisone—multiple sclerosis	0.000124	0.000293	CcSEcCtD
Ropinirole—Shock—Dexamethasone—multiple sclerosis	0.000124	0.000293	CcSEcCtD
Ropinirole—Shock—Betamethasone—multiple sclerosis	0.000124	0.000293	CcSEcCtD
Ropinirole—Dyspnoea—Triamcinolone—multiple sclerosis	0.000124	0.000292	CcSEcCtD
Ropinirole—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000123	0.000292	CcSEcCtD
Ropinirole—Nervous system disorder—Betamethasone—multiple sclerosis	0.000123	0.000292	CcSEcCtD
Ropinirole—Agitation—Prednisone—multiple sclerosis	0.000123	0.000292	CcSEcCtD
Ropinirole—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000123	0.000291	CcSEcCtD
Ropinirole—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000123	0.000291	CcSEcCtD
Ropinirole—Tachycardia—Betamethasone—multiple sclerosis	0.000123	0.00029	CcSEcCtD
Ropinirole—Tachycardia—Dexamethasone—multiple sclerosis	0.000123	0.00029	CcSEcCtD
Ropinirole—Angioedema—Prednisone—multiple sclerosis	0.000123	0.00029	CcSEcCtD
Ropinirole—Dyspepsia—Triamcinolone—multiple sclerosis	0.000122	0.000289	CcSEcCtD
Ropinirole—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000122	0.000288	CcSEcCtD
Ropinirole—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000122	0.000288	CcSEcCtD
Ropinirole—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000122	0.000288	CcSEcCtD
Ropinirole—Malaise—Prednisone—multiple sclerosis	0.000121	0.000286	CcSEcCtD
Ropinirole—Vertigo—Prednisone—multiple sclerosis	0.000121	0.000285	CcSEcCtD
Ropinirole—Eye disorder—Methotrexate—multiple sclerosis	0.00012	0.000285	CcSEcCtD
Ropinirole—Syncope—Prednisone—multiple sclerosis	0.00012	0.000285	CcSEcCtD
Ropinirole—Tinnitus—Methotrexate—multiple sclerosis	0.00012	0.000284	CcSEcCtD
Ropinirole—Anorexia—Betamethasone—multiple sclerosis	0.00012	0.000284	CcSEcCtD
Ropinirole—Anorexia—Dexamethasone—multiple sclerosis	0.00012	0.000284	CcSEcCtD
Ropinirole—Urticaria—Prednisolone—multiple sclerosis	0.00012	0.000283	CcSEcCtD
Ropinirole—Cardiac disorder—Methotrexate—multiple sclerosis	0.00012	0.000283	CcSEcCtD
Ropinirole—Fatigue—Triamcinolone—multiple sclerosis	0.00012	0.000283	CcSEcCtD
Ropinirole—Fatigue—Methylprednisolone—multiple sclerosis	0.000119	0.000282	CcSEcCtD
Ropinirole—Pain—Triamcinolone—multiple sclerosis	0.000119	0.00028	CcSEcCtD
Ropinirole—Loss of consciousness—Prednisone—multiple sclerosis	0.000118	0.000279	CcSEcCtD
Ropinirole—Hypotension—Dexamethasone—multiple sclerosis	0.000118	0.000278	CcSEcCtD
Ropinirole—Hypotension—Betamethasone—multiple sclerosis	0.000118	0.000278	CcSEcCtD
Ropinirole—Angiopathy—Methotrexate—multiple sclerosis	0.000117	0.000277	CcSEcCtD
Ropinirole—Vomiting—Mitoxantrone—multiple sclerosis	0.000117	0.000276	CcSEcCtD
Ropinirole—Immune system disorder—Methotrexate—multiple sclerosis	0.000116	0.000275	CcSEcCtD
Ropinirole—Convulsion—Prednisone—multiple sclerosis	0.000116	0.000275	CcSEcCtD
Ropinirole—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000116	0.000275	CcSEcCtD
Ropinirole—Hypertension—Prednisone—multiple sclerosis	0.000116	0.000274	CcSEcCtD
Ropinirole—Rash—Mitoxantrone—multiple sclerosis	0.000116	0.000274	CcSEcCtD
Ropinirole—Dermatitis—Mitoxantrone—multiple sclerosis	0.000116	0.000274	CcSEcCtD
Ropinirole—Chills—Methotrexate—multiple sclerosis	0.000116	0.000273	CcSEcCtD
Ropinirole—Headache—Mitoxantrone—multiple sclerosis	0.000115	0.000272	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000115	0.000271	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000115	0.000271	CcSEcCtD
Ropinirole—Arthralgia—Prednisone—multiple sclerosis	0.000114	0.00027	CcSEcCtD
Ropinirole—Myalgia—Prednisone—multiple sclerosis	0.000114	0.00027	CcSEcCtD
Ropinirole—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000114	0.00027	CcSEcCtD
Ropinirole—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000114	0.00027	CcSEcCtD
Ropinirole—Anxiety—Prednisone—multiple sclerosis	0.000114	0.000269	CcSEcCtD
Ropinirole—Alopecia—Methotrexate—multiple sclerosis	0.000114	0.000269	CcSEcCtD
Ropinirole—Insomnia—Dexamethasone—multiple sclerosis	0.000114	0.000269	CcSEcCtD
Ropinirole—Insomnia—Betamethasone—multiple sclerosis	0.000114	0.000269	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000113	0.000268	CcSEcCtD
Ropinirole—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000113	0.000268	CcSEcCtD
Ropinirole—Paraesthesia—Dexamethasone—multiple sclerosis	0.000113	0.000267	CcSEcCtD
Ropinirole—Paraesthesia—Betamethasone—multiple sclerosis	0.000113	0.000267	CcSEcCtD
Ropinirole—Discomfort—Prednisone—multiple sclerosis	0.000113	0.000267	CcSEcCtD
Ropinirole—Mental disorder—Methotrexate—multiple sclerosis	0.000113	0.000267	CcSEcCtD
Ropinirole—Malnutrition—Methotrexate—multiple sclerosis	0.000112	0.000265	CcSEcCtD
Ropinirole—Hypersensitivity—Prednisolone—multiple sclerosis	0.000111	0.000263	CcSEcCtD
Ropinirole—Dyspepsia—Dexamethasone—multiple sclerosis	0.000111	0.000262	CcSEcCtD
Ropinirole—Dyspepsia—Betamethasone—multiple sclerosis	0.000111	0.000262	CcSEcCtD
Ropinirole—Urticaria—Triamcinolone—multiple sclerosis	0.00011	0.00026	CcSEcCtD
Ropinirole—Urticaria—Methylprednisolone—multiple sclerosis	0.00011	0.00026	CcSEcCtD
Ropinirole—Dysgeusia—Methotrexate—multiple sclerosis	0.00011	0.00026	CcSEcCtD
Ropinirole—Body temperature increased—Triamcinolone—multiple sclerosis	0.00011	0.000259	CcSEcCtD
Ropinirole—Oedema—Prednisone—multiple sclerosis	0.00011	0.000259	CcSEcCtD
Ropinirole—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000109	0.000259	CcSEcCtD
Ropinirole—Decreased appetite—Dexamethasone—multiple sclerosis	0.000109	0.000259	CcSEcCtD
Ropinirole—Decreased appetite—Betamethasone—multiple sclerosis	0.000109	0.000259	CcSEcCtD
Ropinirole—Nausea—Mitoxantrone—multiple sclerosis	0.000109	0.000258	CcSEcCtD
Ropinirole—Infection—Prednisone—multiple sclerosis	0.000109	0.000257	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000109	0.000257	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000109	0.000257	CcSEcCtD
Ropinirole—Back pain—Methotrexate—multiple sclerosis	0.000108	0.000257	CcSEcCtD
Ropinirole—Fatigue—Dexamethasone—multiple sclerosis	0.000108	0.000256	CcSEcCtD
Ropinirole—Fatigue—Betamethasone—multiple sclerosis	0.000108	0.000256	CcSEcCtD
Ropinirole—Shock—Prednisone—multiple sclerosis	0.000108	0.000255	CcSEcCtD
Ropinirole—Pain—Betamethasone—multiple sclerosis	0.000108	0.000254	CcSEcCtD
Ropinirole—Pain—Dexamethasone—multiple sclerosis	0.000108	0.000254	CcSEcCtD
Ropinirole—Nervous system disorder—Prednisone—multiple sclerosis	0.000107	0.000254	CcSEcCtD
Ropinirole—Tachycardia—Prednisone—multiple sclerosis	0.000107	0.000253	CcSEcCtD
Ropinirole—Skin disorder—Prednisone—multiple sclerosis	0.000106	0.000252	CcSEcCtD
Ropinirole—Hyperhidrosis—Prednisone—multiple sclerosis	0.000106	0.00025	CcSEcCtD
Ropinirole—Vision blurred—Methotrexate—multiple sclerosis	0.000106	0.00025	CcSEcCtD
Ropinirole—Anorexia—Prednisone—multiple sclerosis	0.000104	0.000247	CcSEcCtD
Ropinirole—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000104	0.000246	CcSEcCtD
Ropinirole—Anaemia—Methotrexate—multiple sclerosis	0.000104	0.000245	CcSEcCtD
Ropinirole—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000104	0.000245	CcSEcCtD
Ropinirole—Feeling abnormal—Betamethasone—multiple sclerosis	0.000104	0.000245	CcSEcCtD
Ropinirole—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000103	0.000243	CcSEcCtD
Ropinirole—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000103	0.000243	CcSEcCtD
Ropinirole—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000102	0.000242	CcSEcCtD
Ropinirole—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000102	0.000241	CcSEcCtD
Ropinirole—Malaise—Methotrexate—multiple sclerosis	0.000101	0.000239	CcSEcCtD
Ropinirole—Vertigo—Methotrexate—multiple sclerosis	0.000101	0.000238	CcSEcCtD
Ropinirole—Leukopenia—Methotrexate—multiple sclerosis	0.0001	0.000237	CcSEcCtD
Ropinirole—Urticaria—Dexamethasone—multiple sclerosis	9.99e-05	0.000236	CcSEcCtD
Ropinirole—Urticaria—Betamethasone—multiple sclerosis	9.99e-05	0.000236	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Prednisone—multiple sclerosis	9.98e-05	0.000236	CcSEcCtD
Ropinirole—Dizziness—Prednisolone—multiple sclerosis	9.97e-05	0.000236	CcSEcCtD
Ropinirole—Asthenia—Triamcinolone—multiple sclerosis	9.95e-05	0.000235	CcSEcCtD
Ropinirole—Body temperature increased—Dexamethasone—multiple sclerosis	9.94e-05	0.000235	CcSEcCtD
Ropinirole—Abdominal pain—Dexamethasone—multiple sclerosis	9.94e-05	0.000235	CcSEcCtD
Ropinirole—Body temperature increased—Betamethasone—multiple sclerosis	9.94e-05	0.000235	CcSEcCtD
Ropinirole—Abdominal pain—Betamethasone—multiple sclerosis	9.94e-05	0.000235	CcSEcCtD
Ropinirole—Asthenia—Methylprednisolone—multiple sclerosis	9.92e-05	0.000235	CcSEcCtD
Ropinirole—Insomnia—Prednisone—multiple sclerosis	9.91e-05	0.000234	CcSEcCtD
Ropinirole—Paraesthesia—Prednisone—multiple sclerosis	9.84e-05	0.000233	CcSEcCtD
Ropinirole—Pruritus—Triamcinolone—multiple sclerosis	9.81e-05	0.000232	CcSEcCtD
Ropinirole—Cough—Methotrexate—multiple sclerosis	9.79e-05	0.000232	CcSEcCtD
Ropinirole—Pruritus—Methylprednisolone—multiple sclerosis	9.79e-05	0.000231	CcSEcCtD
Ropinirole—Convulsion—Methotrexate—multiple sclerosis	9.72e-05	0.00023	CcSEcCtD
Ropinirole—Dyspepsia—Prednisone—multiple sclerosis	9.64e-05	0.000228	CcSEcCtD
Ropinirole—Arthralgia—Methotrexate—multiple sclerosis	9.55e-05	0.000226	CcSEcCtD
Ropinirole—Myalgia—Methotrexate—multiple sclerosis	9.55e-05	0.000226	CcSEcCtD
Ropinirole—Chest pain—Methotrexate—multiple sclerosis	9.55e-05	0.000226	CcSEcCtD
Ropinirole—Decreased appetite—Prednisone—multiple sclerosis	9.52e-05	0.000225	CcSEcCtD
Ropinirole—Rash—Prednisolone—multiple sclerosis	9.5e-05	0.000225	CcSEcCtD
Ropinirole—Dermatitis—Prednisolone—multiple sclerosis	9.5e-05	0.000225	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	9.48e-05	0.000224	CcSEcCtD
Ropinirole—Diarrhoea—Methylprednisolone—multiple sclerosis	9.46e-05	0.000224	CcSEcCtD
Ropinirole—Fatigue—Prednisone—multiple sclerosis	9.44e-05	0.000223	CcSEcCtD
Ropinirole—Headache—Prednisolone—multiple sclerosis	9.44e-05	0.000223	CcSEcCtD
Ropinirole—Discomfort—Methotrexate—multiple sclerosis	9.43e-05	0.000223	CcSEcCtD
Ropinirole—Constipation—Prednisone—multiple sclerosis	9.37e-05	0.000222	CcSEcCtD
Ropinirole—Confusional state—Methotrexate—multiple sclerosis	9.23e-05	0.000218	CcSEcCtD
Ropinirole—Dizziness—Triamcinolone—multiple sclerosis	9.17e-05	0.000217	CcSEcCtD
Ropinirole—Dizziness—Methylprednisolone—multiple sclerosis	9.15e-05	0.000216	CcSEcCtD
Ropinirole—Infection—Methotrexate—multiple sclerosis	9.09e-05	0.000215	CcSEcCtD
Ropinirole—Feeling abnormal—Prednisone—multiple sclerosis	9.03e-05	0.000214	CcSEcCtD
Ropinirole—Asthenia—Betamethasone—multiple sclerosis	9.02e-05	0.000213	CcSEcCtD
Ropinirole—Asthenia—Dexamethasone—multiple sclerosis	9.02e-05	0.000213	CcSEcCtD
Ropinirole—Nervous system disorder—Methotrexate—multiple sclerosis	8.98e-05	0.000212	CcSEcCtD
Ropinirole—Thrombocytopenia—Methotrexate—multiple sclerosis	8.96e-05	0.000212	CcSEcCtD
Ropinirole—Gastrointestinal pain—Prednisone—multiple sclerosis	8.96e-05	0.000212	CcSEcCtD
Ropinirole—Nausea—Prednisolone—multiple sclerosis	8.95e-05	0.000212	CcSEcCtD
Ropinirole—Pruritus—Dexamethasone—multiple sclerosis	8.9e-05	0.00021	CcSEcCtD
Ropinirole—Pruritus—Betamethasone—multiple sclerosis	8.9e-05	0.00021	CcSEcCtD
Ropinirole—Skin disorder—Methotrexate—multiple sclerosis	8.89e-05	0.00021	CcSEcCtD
Ropinirole—Hyperhidrosis—Methotrexate—multiple sclerosis	8.85e-05	0.000209	CcSEcCtD
Ropinirole—Vomiting—Triamcinolone—multiple sclerosis	8.81e-05	0.000208	CcSEcCtD
Ropinirole—Vomiting—Methylprednisolone—multiple sclerosis	8.79e-05	0.000208	CcSEcCtD
Ropinirole—Rash—Triamcinolone—multiple sclerosis	8.74e-05	0.000207	CcSEcCtD
Ropinirole—Dermatitis—Triamcinolone—multiple sclerosis	8.73e-05	0.000207	CcSEcCtD
Ropinirole—Anorexia—Methotrexate—multiple sclerosis	8.73e-05	0.000206	CcSEcCtD
Ropinirole—Rash—Methylprednisolone—multiple sclerosis	8.72e-05	0.000206	CcSEcCtD
Ropinirole—Dermatitis—Methylprednisolone—multiple sclerosis	8.71e-05	0.000206	CcSEcCtD
Ropinirole—Urticaria—Prednisone—multiple sclerosis	8.7e-05	0.000206	CcSEcCtD
Ropinirole—Headache—Triamcinolone—multiple sclerosis	8.68e-05	0.000205	CcSEcCtD
Ropinirole—Headache—Methylprednisolone—multiple sclerosis	8.66e-05	0.000205	CcSEcCtD
Ropinirole—Abdominal pain—Prednisone—multiple sclerosis	8.66e-05	0.000205	CcSEcCtD
Ropinirole—Body temperature increased—Prednisone—multiple sclerosis	8.66e-05	0.000205	CcSEcCtD
Ropinirole—Diarrhoea—Betamethasone—multiple sclerosis	8.61e-05	0.000204	CcSEcCtD
Ropinirole—Diarrhoea—Dexamethasone—multiple sclerosis	8.61e-05	0.000204	CcSEcCtD
Ropinirole—Hypotension—Methotrexate—multiple sclerosis	8.55e-05	0.000202	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	8.34e-05	0.000197	CcSEcCtD
Ropinirole—Dizziness—Dexamethasone—multiple sclerosis	8.32e-05	0.000197	CcSEcCtD
Ropinirole—Dizziness—Betamethasone—multiple sclerosis	8.32e-05	0.000197	CcSEcCtD
Ropinirole—Insomnia—Methotrexate—multiple sclerosis	8.28e-05	0.000196	CcSEcCtD
Ropinirole—Nausea—Triamcinolone—multiple sclerosis	8.23e-05	0.000195	CcSEcCtD
Ropinirole—Paraesthesia—Methotrexate—multiple sclerosis	8.22e-05	0.000194	CcSEcCtD
Ropinirole—Nausea—Methylprednisolone—multiple sclerosis	8.22e-05	0.000194	CcSEcCtD
Ropinirole—Dyspnoea—Methotrexate—multiple sclerosis	8.16e-05	0.000193	CcSEcCtD
Ropinirole—Somnolence—Methotrexate—multiple sclerosis	8.14e-05	0.000192	CcSEcCtD
Ropinirole—Hypersensitivity—Prednisone—multiple sclerosis	8.07e-05	0.000191	CcSEcCtD
Ropinirole—Dyspepsia—Methotrexate—multiple sclerosis	8.06e-05	0.000191	CcSEcCtD
Ropinirole—Vomiting—Betamethasone—multiple sclerosis	8e-05	0.000189	CcSEcCtD
Ropinirole—Vomiting—Dexamethasone—multiple sclerosis	8e-05	0.000189	CcSEcCtD
Ropinirole—Decreased appetite—Methotrexate—multiple sclerosis	7.96e-05	0.000188	CcSEcCtD
Ropinirole—Rash—Dexamethasone—multiple sclerosis	7.93e-05	0.000188	CcSEcCtD
Ropinirole—Rash—Betamethasone—multiple sclerosis	7.93e-05	0.000188	CcSEcCtD
Ropinirole—Dermatitis—Betamethasone—multiple sclerosis	7.92e-05	0.000187	CcSEcCtD
Ropinirole—Dermatitis—Dexamethasone—multiple sclerosis	7.92e-05	0.000187	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Methotrexate—multiple sclerosis	7.9e-05	0.000187	CcSEcCtD
Ropinirole—Fatigue—Methotrexate—multiple sclerosis	7.89e-05	0.000187	CcSEcCtD
Ropinirole—Headache—Dexamethasone—multiple sclerosis	7.88e-05	0.000186	CcSEcCtD
Ropinirole—Headache—Betamethasone—multiple sclerosis	7.88e-05	0.000186	CcSEcCtD
Ropinirole—Asthenia—Prednisone—multiple sclerosis	7.86e-05	0.000186	CcSEcCtD
Ropinirole—Pain—Methotrexate—multiple sclerosis	7.83e-05	0.000185	CcSEcCtD
Ropinirole—Pruritus—Prednisone—multiple sclerosis	7.75e-05	0.000183	CcSEcCtD
Ropinirole—Feeling abnormal—Methotrexate—multiple sclerosis	7.54e-05	0.000178	CcSEcCtD
Ropinirole—Diarrhoea—Prednisone—multiple sclerosis	7.49e-05	0.000177	CcSEcCtD
Ropinirole—Gastrointestinal pain—Methotrexate—multiple sclerosis	7.49e-05	0.000177	CcSEcCtD
Ropinirole—Nausea—Betamethasone—multiple sclerosis	7.47e-05	0.000177	CcSEcCtD
Ropinirole—Nausea—Dexamethasone—multiple sclerosis	7.47e-05	0.000177	CcSEcCtD
Ropinirole—Urticaria—Methotrexate—multiple sclerosis	7.27e-05	0.000172	CcSEcCtD
Ropinirole—Dizziness—Prednisone—multiple sclerosis	7.24e-05	0.000171	CcSEcCtD
Ropinirole—Body temperature increased—Methotrexate—multiple sclerosis	7.24e-05	0.000171	CcSEcCtD
Ropinirole—Abdominal pain—Methotrexate—multiple sclerosis	7.24e-05	0.000171	CcSEcCtD
Ropinirole—Vomiting—Prednisone—multiple sclerosis	6.96e-05	0.000165	CcSEcCtD
Ropinirole—Rash—Prednisone—multiple sclerosis	6.91e-05	0.000163	CcSEcCtD
Ropinirole—Dermatitis—Prednisone—multiple sclerosis	6.9e-05	0.000163	CcSEcCtD
Ropinirole—Headache—Prednisone—multiple sclerosis	6.86e-05	0.000162	CcSEcCtD
Ropinirole—Hypersensitivity—Methotrexate—multiple sclerosis	6.74e-05	0.00016	CcSEcCtD
Ropinirole—Asthenia—Methotrexate—multiple sclerosis	6.57e-05	0.000155	CcSEcCtD
Ropinirole—Nausea—Prednisone—multiple sclerosis	6.51e-05	0.000154	CcSEcCtD
Ropinirole—Pruritus—Methotrexate—multiple sclerosis	6.48e-05	0.000153	CcSEcCtD
Ropinirole—Diarrhoea—Methotrexate—multiple sclerosis	6.26e-05	0.000148	CcSEcCtD
Ropinirole—Dizziness—Methotrexate—multiple sclerosis	6.05e-05	0.000143	CcSEcCtD
Ropinirole—Vomiting—Methotrexate—multiple sclerosis	5.82e-05	0.000138	CcSEcCtD
Ropinirole—Rash—Methotrexate—multiple sclerosis	5.77e-05	0.000137	CcSEcCtD
Ropinirole—Dermatitis—Methotrexate—multiple sclerosis	5.77e-05	0.000136	CcSEcCtD
Ropinirole—Headache—Methotrexate—multiple sclerosis	5.73e-05	0.000136	CcSEcCtD
Ropinirole—Nausea—Methotrexate—multiple sclerosis	5.44e-05	0.000129	CcSEcCtD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.81e-05	0.000114	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—APOE—multiple sclerosis	1.81e-05	0.000113	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.8e-05	0.000113	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—APOE—multiple sclerosis	1.8e-05	0.000113	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—POMC—multiple sclerosis	1.79e-05	0.000112	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	1.79e-05	0.000112	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—APOE—multiple sclerosis	1.79e-05	0.000112	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—IL2—multiple sclerosis	1.78e-05	0.000112	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	1.78e-05	0.000112	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	1.77e-05	0.000111	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	1.77e-05	0.000111	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	1.76e-05	0.00011	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—POMC—multiple sclerosis	1.76e-05	0.00011	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—CCL2—multiple sclerosis	1.75e-05	0.00011	CbGpPWpGaD
Ropinirole—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	1.75e-05	0.00011	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	1.75e-05	0.00011	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	1.75e-05	0.000109	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	1.74e-05	0.000109	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	1.74e-05	0.000109	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CD80—multiple sclerosis	1.74e-05	0.000109	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	1.73e-05	0.000109	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	1.73e-05	0.000109	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—IL2—multiple sclerosis	1.73e-05	0.000108	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—POMC—multiple sclerosis	1.73e-05	0.000108	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—IL6—multiple sclerosis	1.72e-05	0.000108	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—CCL2—multiple sclerosis	1.72e-05	0.000108	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—MAPK1—multiple sclerosis	1.72e-05	0.000108	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	1.71e-05	0.000107	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	1.7e-05	0.000107	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—SPP1—multiple sclerosis	1.7e-05	0.000107	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CD86—multiple sclerosis	1.69e-05	0.000106	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—CCL2—multiple sclerosis	1.69e-05	0.000106	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	1.69e-05	0.000106	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—MAPK1—multiple sclerosis	1.68e-05	0.000105	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	1.68e-05	0.000105	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	1.67e-05	0.000105	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCL5—multiple sclerosis	1.67e-05	0.000105	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CD86—multiple sclerosis	1.67e-05	0.000104	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	1.67e-05	0.000104	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CCR5—multiple sclerosis	1.66e-05	0.000104	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—MAPK1—multiple sclerosis	1.65e-05	0.000104	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—POMC—multiple sclerosis	1.65e-05	0.000103	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	1.64e-05	0.000103	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—MMP9—multiple sclerosis	1.64e-05	0.000103	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CD80—multiple sclerosis	1.64e-05	0.000103	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL2RA—multiple sclerosis	1.63e-05	0.000102	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—IL2—multiple sclerosis	1.62e-05	0.000101	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	1.62e-05	0.000101	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CD80—multiple sclerosis	1.62e-05	0.000101	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—CCL2—multiple sclerosis	1.61e-05	0.000101	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	1.61e-05	0.000101	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TYK2—multiple sclerosis	1.59e-05	9.98e-05	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	1.59e-05	9.98e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.59e-05	9.93e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	1.58e-05	9.91e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—MAPK1—multiple sclerosis	1.58e-05	9.89e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TYK2—multiple sclerosis	1.56e-05	9.77e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.56e-05	9.76e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—APOE—multiple sclerosis	1.56e-05	9.76e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—POMC—multiple sclerosis	1.56e-05	9.75e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—APOE—multiple sclerosis	1.55e-05	9.71e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—POMC—multiple sclerosis	1.55e-05	9.7e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—SPP1—multiple sclerosis	1.54e-05	9.68e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TYK2—multiple sclerosis	1.54e-05	9.62e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—POMC—multiple sclerosis	1.53e-05	9.62e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—CCL2—multiple sclerosis	1.52e-05	9.54e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	1.52e-05	9.52e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	1.52e-05	9.5e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—APOE—multiple sclerosis	1.51e-05	9.44e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCR5—multiple sclerosis	1.5e-05	9.41e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—CCL2—multiple sclerosis	1.5e-05	9.41e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	1.49e-05	9.35e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—MAPK1—multiple sclerosis	1.49e-05	9.33e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	1.48e-05	9.28e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	1.48e-05	9.26e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—IL2—multiple sclerosis	1.47e-05	9.21e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—MAPK1—multiple sclerosis	1.47e-05	9.21e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	1.47e-05	9.18e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—APOE—multiple sclerosis	1.46e-05	9.17e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	1.46e-05	9.14e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	1.46e-05	9.13e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—STAT3—multiple sclerosis	1.46e-05	9.12e-05	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	1.45e-05	9.08e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	1.45e-05	9.06e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.42e-05	8.9e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—ALB—multiple sclerosis	1.41e-05	8.84e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CD80—multiple sclerosis	1.41e-05	8.82e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CD80—multiple sclerosis	1.4e-05	8.77e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	1.39e-05	8.68e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	1.38e-05	8.66e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TYK2—multiple sclerosis	1.38e-05	8.66e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—APOE—multiple sclerosis	1.37e-05	8.57e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TYK2—multiple sclerosis	1.36e-05	8.54e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CD80—multiple sclerosis	1.36e-05	8.53e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	1.36e-05	8.49e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—MYC—multiple sclerosis	1.35e-05	8.48e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—TGFB1—multiple sclerosis	1.35e-05	8.46e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	1.35e-05	8.43e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—APOE—multiple sclerosis	1.35e-05	8.43e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—BCHE—multiple sclerosis	1.34e-05	8.41e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—POMC—multiple sclerosis	1.34e-05	8.38e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—POMC—multiple sclerosis	1.33e-05	8.34e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	1.33e-05	8.31e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—IL2—multiple sclerosis	1.33e-05	8.31e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	1.33e-05	8.31e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—MAPK1—multiple sclerosis	1.32e-05	8.29e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—IL6—multiple sclerosis	1.32e-05	8.26e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	1.32e-05	8.24e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	1.31e-05	8.2e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	1.3e-05	8.16e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—IL2—multiple sclerosis	1.3e-05	8.13e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—POMC—multiple sclerosis	1.29e-05	8.11e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—IL6—multiple sclerosis	1.29e-05	8.09e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	1.28e-05	8.02e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—IL2—multiple sclerosis	1.28e-05	8e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.27e-05	7.98e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—IL6—multiple sclerosis	1.27e-05	7.96e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—CCL2—multiple sclerosis	1.27e-05	7.93e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—POMC—multiple sclerosis	1.26e-05	7.88e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MMP9—multiple sclerosis	1.25e-05	7.86e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—MAPK1—multiple sclerosis	1.24e-05	7.76e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CD80—multiple sclerosis	1.24e-05	7.74e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	1.23e-05	7.71e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	1.23e-05	7.7e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	1.22e-05	7.67e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—IL2—multiple sclerosis	1.22e-05	7.64e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CD80—multiple sclerosis	1.22e-05	7.62e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	1.21e-05	7.6e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MMP9—multiple sclerosis	1.21e-05	7.57e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	1.19e-05	7.45e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	1.18e-05	7.41e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—POMC—multiple sclerosis	1.17e-05	7.36e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—POMC—multiple sclerosis	1.16e-05	7.24e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	1.15e-05	7.23e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TYK2—multiple sclerosis	1.15e-05	7.2e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—IL2—multiple sclerosis	1.15e-05	7.2e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—CCL2—multiple sclerosis	1.15e-05	7.2e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—ALB—multiple sclerosis	1.15e-05	7.18e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—IL6—multiple sclerosis	1.14e-05	7.17e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—IL2—multiple sclerosis	1.13e-05	7.11e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	1.13e-05	7.08e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—IL6—multiple sclerosis	1.13e-05	7.07e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1.12e-05	7.04e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—STAT3—multiple sclerosis	1.12e-05	6.99e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	1.11e-05	6.93e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.11e-05	6.93e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	1.09e-05	6.84e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MMP9—multiple sclerosis	1.09e-05	6.82e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—STAT3—multiple sclerosis	1.07e-05	6.73e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MMP9—multiple sclerosis	1.07e-05	6.73e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	1.05e-05	6.59e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TYK2—multiple sclerosis	1.04e-05	6.54e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MYC—multiple sclerosis	1.04e-05	6.49e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.04e-05	6.49e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TGFB1—multiple sclerosis	1.03e-05	6.48e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	1.03e-05	6.44e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	1.03e-05	6.43e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	1.03e-05	6.43e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	1.02e-05	6.42e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	1.02e-05	6.39e-05	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—IL6—multiple sclerosis	1.02e-05	6.37e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MYC—multiple sclerosis	1.01e-05	6.36e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—MAPK1—multiple sclerosis	1.01e-05	6.35e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	1.01e-05	6.34e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	1.01e-05	6.31e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MYC—multiple sclerosis	9.99e-06	6.26e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TGFB1—multiple sclerosis	9.96e-06	6.24e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	9.93e-06	6.22e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL2—multiple sclerosis	9.89e-06	6.2e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	9.84e-06	6.16e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL2—multiple sclerosis	9.84e-06	6.16e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	9.79e-06	6.13e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—MAPK1—multiple sclerosis	9.77e-06	6.12e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	9.69e-06	6.07e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—STAT3—multiple sclerosis	9.68e-06	6.06e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL2—multiple sclerosis	9.57e-06	6e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—STAT3—multiple sclerosis	9.55e-06	5.98e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—APOE—multiple sclerosis	9.54e-06	5.98e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MYC—multiple sclerosis	9.53e-06	5.97e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—IL6—multiple sclerosis	9.52e-06	5.97e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	9.51e-06	5.96e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	9.36e-06	5.86e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	9.34e-06	5.85e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	9.33e-06	5.84e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	9.31e-06	5.83e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MMP9—multiple sclerosis	9.06e-06	5.67e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MYC—multiple sclerosis	8.99e-06	5.63e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TGFB1—multiple sclerosis	8.97e-06	5.62e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MYC—multiple sclerosis	8.87e-06	5.56e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TGFB1—multiple sclerosis	8.85e-06	5.55e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—MAPK1—multiple sclerosis	8.8e-06	5.51e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL2—multiple sclerosis	8.68e-06	5.44e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—MAPK1—multiple sclerosis	8.68e-06	5.44e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—IL6—multiple sclerosis	8.64e-06	5.41e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	8.62e-06	5.4e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL2—multiple sclerosis	8.54e-06	5.35e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	8.5e-06	5.33e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	8.32e-06	5.21e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	8.28e-06	5.19e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MMP9—multiple sclerosis	8.22e-06	5.15e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—POMC—multiple sclerosis	8.19e-06	5.13e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	8.09e-06	5.07e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—APOE—multiple sclerosis	8.08e-06	5.06e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—STAT3—multiple sclerosis	8.05e-06	5.04e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	8.01e-06	5.02e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	7.99e-06	5.01e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	7.84e-06	4.91e-05	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—IL6—multiple sclerosis	7.79e-06	4.88e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	7.77e-06	4.87e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	7.73e-06	4.85e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MYC—multiple sclerosis	7.73e-06	4.84e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	7.71e-06	4.83e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MYC—multiple sclerosis	7.69e-06	4.82e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	7.67e-06	4.81e-05	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—IL6—multiple sclerosis	7.63e-06	4.78e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	7.56e-06	4.74e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	7.53e-06	4.71e-05	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—IL6—multiple sclerosis	7.51e-06	4.7e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MYC—multiple sclerosis	7.48e-06	4.69e-05	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—ALB—multiple sclerosis	7.47e-06	4.68e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TGFB1—multiple sclerosis	7.46e-06	4.68e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	7.36e-06	4.61e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—MAPK1—multiple sclerosis	7.32e-06	4.59e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—STAT3—multiple sclerosis	7.31e-06	4.58e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	7.19e-06	4.5e-05	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—IL6—multiple sclerosis	7.17e-06	4.49e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—POMC—multiple sclerosis	6.94e-06	4.35e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MYC—multiple sclerosis	6.79e-06	4.25e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	6.77e-06	4.24e-05	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—IL6—multiple sclerosis	6.76e-06	4.23e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MYC—multiple sclerosis	6.68e-06	4.19e-05	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—IL6—multiple sclerosis	6.67e-06	4.18e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	6.66e-06	4.18e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	6.64e-06	4.16e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	6.54e-06	4.1e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	6.53e-06	4.09e-05	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—ALB—multiple sclerosis	6.33e-06	3.96e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—APOE—multiple sclerosis	6.24e-06	3.91e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	6.08e-06	3.81e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	6.06e-06	3.8e-05	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	6.02e-06	3.77e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	5.95e-06	3.72e-05	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—IL6—multiple sclerosis	5.81e-06	3.64e-05	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—IL6—multiple sclerosis	5.78e-06	3.62e-05	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—IL6—multiple sclerosis	5.62e-06	3.52e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—POMC—multiple sclerosis	5.36e-06	3.36e-05	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—IL6—multiple sclerosis	5.1e-06	3.2e-05	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—IL6—multiple sclerosis	5.02e-06	3.15e-05	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—ALB—multiple sclerosis	4.88e-06	3.06e-05	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	4.57e-06	2.86e-05	CbGpPWpGaD
